Effect of metformin treatment on coronary heart disease risk factors and soluble adhesion molecules in patients with type 2 diabetes mellitus

被引:0
|
作者
Abbasi, F
Chu, JW
Lamendola, C
McLaughlin, T
Schaaf, P
Reaven, GM
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2067
引用
收藏
页码:A503 / A503
页数:1
相关论文
共 50 条
  • [21] The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus
    Takeuchi, N
    Kawamura, T
    Kanai, A
    Nakamura, N
    Uno, T
    Hara, T
    Sano, T
    Sakamoto, N
    Hamada, Y
    Nakamura, J
    Hotta, N
    DIABETIC MEDICINE, 2002, 19 (01) : 57 - 64
  • [22] Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease
    Moradi, Nariman
    Fadaei, Reza
    Emamgholipour, Solaleh
    Kazemian, Elham
    Panahi, Ghodratollah
    Vahedi, Siamak
    Saed, Lotfolah
    Fallah, Soudabeh
    PLOS ONE, 2018, 13 (01):
  • [23] Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
    Evans, Josie M. M.
    Doney, Alex S. F.
    AlZadjali, Matlooba A.
    Ogston, Simon A.
    Petrie, John R.
    Morris, Andrew D.
    Struthers, Allan D.
    Wong, Aaron K. F.
    Lang, Chim C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07): : 1006 - 1010
  • [24] Factors influencing accelerated aging in patients with type 2 diabetes mellitus and coronary heart disease
    Huang, Zehua
    Liu, Nana
    Chen, Shiyi
    Chen, Zhiren
    Wang, Peian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease
    Kruszelnicka, Olga
    Chyrchel, Bernadeta
    Golay, Alain
    Surdacki, Andrzej
    AMINO ACIDS, 2015, 47 (09) : 1951 - 1959
  • [26] Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease
    Olga Kruszelnicka
    Bernadeta Chyrchel
    Alain Golay
    Andrzej Surdacki
    Amino Acids, 2015, 47 : 1951 - 1959
  • [27] Leptin levels are not related to risk factors for coronary heart disease in patients with type 2 diabetes mellitus or normal controls
    Melidonis, A
    Iraklianou, S
    Tournis, S
    Konstandellou, I
    Tsatsoulis, A
    Foussas, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (09): : 502 - 508
  • [28] Risk factors and glycation end products in patients with different forms of coronary heart disease and type 2 diabetes mellitus
    Ivannikova, E. V.
    Kalashnikov, V. Yu.
    Smirnova, O. M.
    Kononenko, I. V.
    Kuznetsov, A. B.
    Terekhin, S. A.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (10) : 19 - 25
  • [29] Smoking and coronary heart disease in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 211 - 211
  • [30] Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus
    Mojiminiyi, OA
    Abdella, N
    Moussa, MA
    Akanji, AO
    Al Mohammedi, H
    Zaki, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 58 (01) : 37 - 44